Discover the rise of "Ozempic face" linked to weight loss drugs like semaglutide, its cosmetic effects, and treatments like ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

CEO-to-be Maziar Mike Doustdar will need to stem the company’s tumbling share price as market pressures intensify.

It seems counterintuitive, if not implausible, that a company which has revolutionised Western health and promises to ...

Madrigal Pharmaceuticals said on Wednesday it has entered into a licensing agreement worth up to $2 billion with China's CSPC Pharmaceutical Group to develop an oral GLP-1 drug for a serious form of ...

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

The Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...

While Ozempic is effective at treating type 2 diabetes and supporting weight loss, it can also come with side effects.

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Shares of Danish drugmaker Novo Nordisk (NVO) traded 8% lower on Wednesday afternoon after the company slashed its full-year ...